Company
Eisbach Bio
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Eisbach Bio is focused on precision oncology. Based in Germany, the firm develops drugs that aim to disrupt tumor growth, going after genetic vulnerabilities within cancer cells. Eisbach pioneers first-in-class therapies with fewer side effects.
Loading relationship preview